Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...

Official data showed that the total value of pharmaceutical exports reached $30,467.32 million in FY25, rising over 9 per ...

In the rapidly evolving landscape of artificial intelligence and data-driven innovation, visionary leadership is becom ...

In a significant achievement, the pharmaceutical exports from India crossed $30 billion in the last financial year (FY25), ...

Cadila Pharma has appointed Hemant Kumar as President - Supply Chain & Procurement at the company.Hemant shared the update ...

According to a study from the Manufacturing Leadership Council, over 70% of manufacturing equipment in North America is more ...

Internship season is in full swing. Career site Glassdoor has published a list of the best internships of the year. It's ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced ...